Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07018869 · ClinicalTrials.gov registry record · Phase 3
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A Phase 3 study of Colorectal Cancer Stage II and Colorectal Cancer Stage III, sponsored by SWOG Cancer Research Network.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,057
- Enrollment target
- 20
- Study locations
NCT07018869 is a Phase 3 study of Colorectal Cancer Stage II and Colorectal Cancer Stage III that is actively recruiting participants, run by SWOG Cancer Research Network. The registered enrollment target is 1,057 participants, above the 921-participant average among 6 other Colorectal Cancer Stage II trials with a reported enrollment target (15% higher). The trial reports 20 study locations across 4 states.
The verdict
NCT07018869, a Phase 3 study of Colorectal Cancer Stage II and Colorectal Cancer Stage III, is actively recruiting participants, sponsored by SWOG Cancer Research Network.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,057 participants
- Enrollment target
- 20
- Study locations
Study Summary
This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that aligns with current guidelines (guideline-concordant). Surveillance care after resection of colorectal cancer is critical to detect potentially curable return of disease (recurrence), yet up to 60% of colorectal cancer survivors fail to receive surveillance. This may be due to a lack of knowledge about the purpose of surveillance care and the risks of cancer recurrence, or a lack of confidence for managing surveillance care. The CTAC intervention is an online education intervention designed to improve patients' knowledge about surveillance and their self-efficacy for managing surveillance, and to promote effective communication with supporters and supporter engagement in patients' surveillance in a way that is aligned with each patient's preferences. By increasing a patient's knowledge, self-efficacy, and satisfaction with their supporter's engagement in their care, the CTAC intervention may increase the number of patients who receive guideline-concordant surveillance care after resection of colorectal cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- OTHER Intervention website access
- OTHER Control website access
Study Locations (20)
California
- Mission Hope Medical Oncology - Arroyo Grande - Arroyo Grande
- Providence Saint Joseph Medical Center/Disney Family Cancer Center - Burbank
- Mercy Cancer Center - Carmichael - Carmichael
- Mercy San Juan Medical Center - Carmichael
- Mercy Cancer Center - Elk Grove - Elk Grove
- Mercy Cancer Center - Merced
- Providence Queen of The Valley - Napa
- Mercy Cancer Center - Rocklin - Rocklin
- Mercy Cancer Center - Sacramento - Sacramento
- Pacific Central Coast Health Center-San Luis Obispo - San Luis Obispo
- Mission Hope Medical Oncology - Santa Maria - Santa Maria
Alaska
- Anchorage Associates in Radiation Medicine - Anchorage
- Alaska Breast Care and Surgery LLC - Anchorage
- Alaska Oncology and Hematology LLC - Anchorage
- Alaska Women's Cancer Care - Anchorage
- Katmai Oncology Group - Anchorage
- Providence Alaska Medical Center - Anchorage
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
- CARTI Cancer Center - Little Rock
Arizona
- Cancer Center at Saint Joseph's - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,057 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2029-06-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07018869
The ClinicalTrials.gov registry entry for NCT07018869 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 1,057 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 921-participant average among 6 other Colorectal Cancer Stage II trials with a reported enrollment target (15% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer Stage II appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT07018869 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alaska, Arkansas.
Frequently Asked Questions
What is clinical trial NCT07018869 about?
NCT07018869 is a clinical study titled "Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors". This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that aligns with current guidelines (guideline-concordant). Surveill...
What is the current status of trial NCT07018869?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,057 participants. The study started on 2025-10-15. Estimated completion is 2029-06-06.
What conditions does trial NCT07018869 study?
This clinical trial studies the following conditions: Colorectal Cancer Stage II, Colorectal Cancer Stage III.
What interventions are being tested in trial NCT07018869?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Intervention website access (OTHER), Control website access (OTHER).
Who is sponsoring clinical trial NCT07018869?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07018869 being conducted?
This trial has 20 study locations across Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Stage II
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Onset Colorectal Cancer Detection
RECRUITING
-
Stage II/III Colorectal Cancer Recurrence
RECRUITING
-
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
RECRUITING · Phase 2
-
Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
RECRUITING
-
Early Detection of Advanced Adenomas and Colorectal Cancer
RECRUITING
-
Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.